Adrenocorticotrophic hormone: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Gareth Leng
(New page: {{subpages}} '''Adrenocorticotrophic hormone''' (ACTH), a product of the Pro-opiomelanocortin (POMC) gene, is a hormone secreted by the corticotrophs of the anterior pituitary in r...)
 
imported>Gareth Leng
(Redirecting to Adrenocorticotropic hormone)
 
(15 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{subpages}}
#REDIRECT [[Adrenocorticotropic hormone]]
'''Adrenocorticotrophic hormone''' (ACTH), a product of the [[Pro-opiomelanocortin]] (POMC) gene, is a hormone secreted by the [[corticotroph]]s of the anterior pituitary in response to [[hypothalamus|hypothalamic]] releasing-factors ([[Corticotrophin Releasing Factor]], CRF). Early studies showed that when the pituitary is disconnected from the hypothalamus, ACTH output falls. Attempts to localise the hypothalamic source of a releasing factor for ACTH focussed attention upon the [[paraventricular nucleus]], and gave rise to the theory that the peptide [[vasopressin]] might be the releasing factor. When given in large amounts, vasopressin will result in ACTH release; the pituitary corticotrophs express a vasopressin receptor subtype (V1b) which differs pharmacologically from both the vascular (V1a) receptors and the renal (V2) receptors; However the hypothesis that vasopressin was the releasing factor for ACTH fell from favour when it became clear that:
 
1)  plasma concentrations of ACTH and vasopressin show no consistent correlation; and
 
2) the [[Brattleboro rat]] hypothalamus has high CRF activity but no vasopressin (The Brattleboro rat is a genetic mutant with hereditary [[diabetes insipidus]] resulting from a total inability to synthesize vasopressin)
 
A 41 amino acid CRF peptide was subsequently isolated and sequenced. This peptide is quite distinct from vasopressin, but is also localised to the paraventricular nucleus. Whereas vasopressin is mainly present in magnocellular neurones which project to the posterior pituitary, CRF is present in parvocellular neurones which project to the external layer of the median eminence, where it is secreted into the portal blood. The CRF neurones contain receptors for glucocorticoids, which exert an inhibitory, negative-feedback control on CRF release.
 
However, while CRF is a potent secretagogue for ACTH, its actions are strongly potentiated in the presence of vasopressin, a finding which gave rise to the suggestion that vasopressin and CRF are co-regulators of ACTH secretion.<ref>Gillies G ''et al.'' (1982) Cortocotropin-releasing activity of the new CRF is potentiated several times by vasopressin ''Nature'' 299, 355-7</ref>
 
Following adrenalectomy, which removes the negative feedback effects of circulating glucocorticoids, the amount of vasopressin in the external layer of the median eminence increases markedly, and this increase can be prevented by replacement of glucocorticoids but not mineralocorticoids; the expression of vasopressin in magnocellular neurones however appeared to be unaffected by adrenalectomy, suggesting that the increased vasopressin in the median eminence must derive from different vasopressin cells.
 
After adrenalectomy, the CRF cells increase their synthesis of CRF, and the CRF-containing terminals in the median eminence increase in number and staining density. Moreover, and Importantly, after adrenalectomy about 79% of the CRF neurones in the paraventricular nucleus also begin to express both vasopressin and its mRNA, suggesting that populations of hypothalamic neurones can "switch on" the synthesis of more than one active substance in response to physiological challenges.
 
Thus ACTH secretion is regulated by a subpopulation of the parvocellular neurones in the paraventricular nucleus. This subpopulation consists of neuroendocrine neurosecretory neurones that project to the median eminence; they normally synthesize CRF but can additionally synthesize vasopressin, especially in response to physiological challenge. Vasopressin and CRF are both secretagogues for ACTH, and in combination they have synergistic actions on ACTH release.
 
==References==
<references/>
*Ma X-M, Lightman SL The arginine vasopressin and corticotrophin-releasing hormone gene transcription responses to varied frequencies of repeated stress in rats ''J Physiol'' 510: 605-
 
*Ferrini MG ''et al.'' (1997) Sex difference in glucocorticoid regulation of vasopressin mRNA in the paraventricular hypothalamic nucleus” ''Cell Mol Neurobiol'' 17: 671-86
 
*Kovacs KJ ''et al.'' (1998) Protein synthesis blockade differentially affects the stress-induced transcriptional activation of neuropeptide genes in parvocellular neurosecretory neurons  ''Mol Brain Res'' 54:85-91
 
*Pelton GH ''et al.'' (1997) Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex ''Brain Res'' 19;778:381-7

Latest revision as of 04:15, 30 December 2010

Redirect to:

Retrieved from "https://citizendium.org/wiki/index.php?title=Adrenocorticotrophic_hormone&oldid=754667"